
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Memphasys Limited is a biotechnology business based in Australia. Memphasys shares (MEM) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Memphasys has a market cap (total outstanding shares value) of $75.5 million.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.033 - $0.16 |
---|---|
50-day moving average | $0.1167 |
200-day moving average | $0.1141 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.003 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.1 on 2021-01-25
1 week (2021-01-18) | -4.76% |
---|---|
1 month (2020-12-24) | 0% |
3 months (2020-10-23) | -13.04% |
6 months (2020-07-24) | -23.08% |
1 year (2020-01-24) | 92.31% |
---|---|
2 years (2019-01-25) | 227.87% |
3 years (2018-01-25) | 238.98% |
5 years (2016-01-25) | 0.81% |
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -8.7% |
Return on equity TTM | -14.33% |
Profit margin | 0% |
Book value | 0.013 |
Market capitalisation | $75.5 million |
TTM: trailing 12 months
We're not expecting Memphasys to pay a dividend over the next 12 months.
Memphasys 's shares were split on a 1:15 basis on 16 August 2018. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Memphasys shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Memphasys shares which in turn could have impacted Memphasys 's share price.
Over the last 12 months, Memphasys 's shares have ranged in value from as little as $0.033 up to $0.16. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Memphasys 's is 0.6946. This would suggest that Memphasys 's shares are less volatile than average (for this exchange).
Memphasys Limited, a bio-separations company, develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that uses high quality sperm cells from semen samples for human assisted reproductive technologies for treating male factor infertility; hydrogels; and other polymer membranes to separate cells from fluids. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited was incorporated in 2006 and is headquartered in Homebush, Australia.
From the best lip exfoliator to the top product for the body, we rounded up the seven best exfoliators you can get in Australia right now.
From the best overall face moisturiser for dry skin to the best body moisturiser, hand moisturiser and tinted moisturiser for dry skin, these are the best 7 moisturisers for dry skin you can buy in Australia right now.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.